alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1


          CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Kathy  Bright,  Chief  Executive  Officer of Radix  Marine  (the  "Company"),
certify,  pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, 18 U.S.C.
Section 1350, that to the best of my knowledge:

         (1)     the  Quarterly  Report on Form  10-QSB of the  Company  for the
                 fiscal  quarter  ended  March  31,  2004 (the  "Report")  fully
                 complies with the  requirements  of Section 13 (a) or 15 (d) of
                 the Securities  Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));
                 and

         (2)     the information contained in the Report fairly presents, in all
                 material  respects,  the  financial  condition  and  results of
                 operations of the Company.

Dated: November 22, 2004

                                    /s/ Kathy Bright
                                    -----------------------
                                    Kathy Bright
                                    Chief Executive Officer
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

Filed: June 15, 2020

* * * * * * * * * * * * * * *

JEREMEY MORGAN

, * No. 19

- 1105 V

*

Petitioner, * Special Master Sanders

*

v. *

*

SECRETARY OF HEALTH * Ruling on Entitlement; Conceded;

AND HUMAN SERVICES, * Influenza (“flu”) Vaccine; Guillain

- Barré

* Syndrome (“GBS”)

Respondent. *

* * * * * * * * * * * * * * *

David J. Carney , Gr een & Schafle, LL C , Philadelphia, PA, for Petitioner.

Dhairya D. Jani , United States Department of Justice, Washington , DC, for Respondent.

RULING ON ENTITLEMENT 1

On July 30, 2019, Jeremy Morgan (“Petitioner”) filed a petition for compensation under

the National Vaccine Injury Compensation Program (“the Program”)

. Pet. at 1, ECF No. 1; 42

U.S.C. § 300aa

- 10 to

- 34 (2012). Petitioner alleges that he developed Guilla in

- Barré syndrome

(“GBS”) as a result of the influenza (“flu”) vaccin e he received on November 2, 2018. Pet. at 1.

On May 26, 2020, Respondent file a report pursuant to Vaccine Rule 4(c) in which he

concedes that P etitioner is entitled to compensation in this case. Resp’t’s Report at 5, ECF No.

13. Specifically, Respondent wrote that it is his “position that [P]etitioner has satisfied the criteria

set forth in the Vaccine Injury Table and Qualifications and Aids to Interpretation[]” for a flu

- GBS

clai m. Id. (citing 42 C.F.R. §§ 100.3(a)(XIV)(D), 100.3(c)(15) ).

1 This decision shall be posted on the United States Court of Federal Claims’ website, in accordance with

the E

- Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of

Electronic Governme nt Services). This means the Decision will be available to anyone with access to

the Internet . In accordance with Vaccine Rule 18(b), a party has 14 days to identify and move to delete

medical or other information that satisfies the criteria in § 300aa

- 12( d)(4)(B). Further, consistent with the

rule requirement, a motion for redaction must include a proposed redacted decision. If, upon review, I agree

that the identified material fits within the requirements of that provision, such material will be deleted f rom

public access.2

A special master may determine whether a petitioner is entitled to compensation based

upon the record. A hearing is not required. § 300aa

- 13; Vaccine Rule 8(d). In light of R espondent's

con cession and my review of the record , I find that Petitioner is entitled to compensation. This

matter shall now proceed to the damages phase.

IT IS SO ORDERED.

s/Herbrina D. Sanders

Herbrina D. Sanders

Special Master
# C_2021422EN.01001002.xml

| 18.10.2021 | EN | Official Journal of the European Union | C 422/10 |
| --- | --- | --- | --- |

18.10.2021

EN

Official Journal of the European Union

C 422/10

---

Judgment of the General Court of 8 September 2021 — Brunswick Bowling Products v Commission

(Case T-152/19) (1)

(Protection of the health and safety of consumers and workers - Directive 2006/42/EC - Safeguard clause - National measure of withdrawal from the market and prohibition of placing on the market of a pinsetter machine and a supplementary kit - Essential health and safety requirements - Commission decision declaring the measure justified - Equal treatment)

(2021/C 422/14)

Language of the case: English

Parties

Applicant: Brunswick Bowling Products LLC, formerly Brunswick Bowling & Billiards Corporation (Muskegon, Michigan, United States) (represented by: R. Martens and V. Ostrovskis, lawyers)

Defendant: European Commission (represented by: M. Huttunen and P. Ondrůšek, acting as Agents)

Intervener in support of the defendant: Kingdom of Sweden (represented by: H. Eklinder, R. Eriksson, C. Meyer-Seitz, A. Runeskjöld, M. Salborn Hodgson, H. Shev, J. Lundberg and O. Simonsson, acting as Agents)

Re:

Application under Article 263 TFEU seeking annulment of Commission Implementing Decision (EU) 2018/1960 of 10 December 2018 on a safeguard measure taken by Sweden pursuant to Directive 2006/42/EC of the European Parliament and of the Council, to prohibit the placing on the market of a type of pinsetter machine and a supplementary kit to be used together with that type of pinsetter machine, manufactured by Brunswick Bowling & Billiards, and to withdraw those machines already placed on the market (OJ 2018 L 315, p. 29).

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Brunswick Bowling Products LLC to pay the costs; |
| --- | --- |

2.

Orders Brunswick Bowling Products LLC to pay the costs;

| 3. | Orders the Kingdom of Sweden to bear its own costs. |
| --- | --- |

3.

Orders the Kingdom of Sweden to bear its own costs.

---

(1)  OJ C 155, 6.5.2019.

---
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S.J. Res. 7 Introduced in Senate (IS)]

112th CONGRESS
  1st Session
S. J. RES. 7

  Providing for the reappointment of Shirley Ann Jackson as a citizen 
     regent of the Board of Regents of the Smithsonian Institution.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 28, 2011

   Mr. Leahy (for himself, Mr. Cochran, and Mr. Reed) introduced the 
 following joint resolution; which was read twice and referred to the 
                 Committee on Rules and Administration

_______________________________________________________________________

                            JOINT RESOLUTION

 
  Providing for the reappointment of Shirley Ann Jackson as a citizen 
     regent of the Board of Regents of the Smithsonian Institution.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That, in accordance with 
section 5581 of the Revised Statutes (20 U.S.C. 43), the vacancy on the 
Board of Regents of the Smithsonian Institution, in the class other 
than Members of Congress, occurring by reason of the expiration of the 
term of Shirley Ann Jackson of New York, is filled by reappointment of 
the incumbent for a term of 6 years, effective May 6, 2011.
                                 <all>
```
FIFTH DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________

Case No. 5D23-2206

LT Case Nos. 2017-CF-1847

 2017-CF-606

 2017-CF-1848

_____________________________

REGINALD DUNNELL,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

_____________________________

On appeal from the Circuit Court for St. Johns County.

R. Lee Smith, Judge.

Deana Marshall, of Law Office of Deana K. Marshall, P.A., 

Riverview, for Appellant.

No Appearance for Appellee.

November 7, 2023

PER CURIAM.

AFFIRMED.

MAKAR, EISNAUGLE, and MACIVER, JJ., concur.
2

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________
EXHIBIT 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the
undersigned officer of Entrust, Inc., a Maryland corporation (the Company), hereby certifies, to such officers knowledge, that:

The
quarterly report on Form 10-Q for the quarter ended June 30, 2007 (the Report) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the
Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                     |  |        |  |                        
|-------------------- |  | ------ |  | -----------------------
|Date: August 8, 2007 |  |        |  | /s/ F. William Conner  
|                     |  | Name:  |  | F. William Conner      
|                     |  | Title: |  | Chief Executive Officer
#### MANDEL, Respondent, v. MANSON et al., Appellants.

(Supreme Court, Appellate Division, Second Department.

October 11, 1907.)

d Action by Elias Mandel against Morris Manson and another.

No opinion. Judgment of the Municipal Court affirmed, with costs.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   12-MOS                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996             DEC-31-1995
<PERIOD-END>                               DEC-31-1996             DEC-31-1995
<CASH>                                           6,619                     127
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    2,580                   3,090
<ALLOWANCES>                                         0                       0
<INVENTORY>                                      6,947                   7,248
<CURRENT-ASSETS>                                16,610                  12,412
<PP&E>                                           2,809                   2,469
<DEPRECIATION>                                   1,285                   1,073
<TOTAL-ASSETS>                                  18,282                  14,298
<CURRENT-LIABILITIES>                            3,592                   9,039
<BONDS>                                          1,757                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                             6                       3
<OTHER-SE>                                      12,709                   5,256
<TOTAL-LIABILITY-AND-EQUITY>                    18,282                  14,298
<SALES>                                         25,000                  24,885
<TOTAL-REVENUES>                                25,000                  24,885
<CGS>                                           17,141                  16,645
<TOTAL-COSTS>                                   17,141                  16,645
<OTHER-EXPENSES>                                   313                   2,806
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                (17)                     386
<INCOME-PRETAX>                                  3,536                   1,103
<INCOME-TAX>                                     1,180                      22
<INCOME-CONTINUING>                              2,356                   1,081
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                     2,356                   1,081
<EPS-PRIMARY>                                     0.45                    0.33
<EPS-DILUTED>                                        0                       0
        

</TABLE>
<TABLE> <S> <C>

<PAGE>







<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                          67,000
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                    236,000
<CURRENT-ASSETS>                             4,915,000
<PP&E>                                         586,000
<DEPRECIATION>                                  57,000
<TOTAL-ASSETS>                               5,459,000
<CURRENT-LIABILITIES>                        1,194,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        27,000
<OTHER-SE>                                   4,229,000
<TOTAL-LIABILITY-AND-EQUITY>                 5,459,000
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                  675,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (594,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (594,000)
<DISCONTINUED>                             (1,200,000)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,794,000)
<EPS-PRIMARY>                                    (.66)
<EPS-DILUTED>                                    (.66)
        





</TABLE>
<PAGE>

                                                                    EXHIBIT 99.1

                            CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
                             18 U.S.C. SECTION 1350

         In connection with the Annual Report of Alkermes Clinical Partners,
L.P. (the "Partnership") on Form 10-K for the year ended December 31, 2002 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Richard F. Pops, President and Chief Executive Officer of Alkermes
Development Corporation II, General Partner of the Partnership, certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section
1350 that:

         1. The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and

         2. The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Partnership.



                                             /s/ Richard F. Pops
                                             ----------------------------------
                                             Richard F. Pops
                                             President and Chief Executive
                                             Officer of Alkermes Development
                                             Corporation II, General Partner of
                                             Alkermes Clinical Partners, L.P.
                                             March 31, 2003
# C_2023024EN.01008402.xml

| 23.1.2023 | EN | Official Journal of the European Union | C 24/84 |
| --- | --- | --- | --- |

23.1.2023

EN

Official Journal of the European Union

C 24/84

---

Order of the General Court of 24 November 2022 — Keller Holdings v Commission

(Case T-764/19) (1)

(2023/C 24/113)

Language of the case: English

The President of the Second Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 45, 10.2.2020.

---
#### Domenico DiMezza, Respondent, v Nancy J. Matteo, Appellant. (And a Third-Party Action.)

[941 NYS2d 261]

In an action to recover damages for personal injuries, the defendant appeals from an order of the Supreme Court, Putnam County (Nicolai, J.), dated March 21, 2011, which denied her motion for summary judgment dismissing the complaint on the ground that the plaintiff did not sustain a serious injury within the meaning of Insurance Law § 5102 (d).

Ordered that the order is reversed, on the law, with costs, and the defendant’s motion for summary judgment dismissing the complaint is granted.

*691The defendant met her prima facie burden of showing that the plaintiff did not sustain a serious injury within the meaning of Insurance Law § 5102 (d) as a result of the subject accident *(see Toure v Avis Rent A Car Sys.,*98 NY2d 345 [2002]; *Gaddy v Eyler,*79 NY2d 955, 956-957 [1992]). The defendant submitted competent medical evidence establishing, prima facie, that the alleged injuries to the lumbar region of the plaintiff s spine and to the plaintiffs left shoulder did not constitute serious injuries within the meaning of Insurance Law § 5102 (d) *(see Staff v Yshua,*59 AD3d 614 [2009]; *Rodriguez v Huerfano,*46 AD3d 794, 795 [2007]). The defendant also submitted evidence establishing, prima facie, that the plaintiff did not sustain a serious injury under the 90/180-day category of Insurance Law § 5102 (d) *(see McIntosh v O’Brien,*69 AD3d 585, 587 [2010]).

In opposition, the plaintiff failed to raise a triable issue of fact. Accordingly, the Supreme Court should have granted the defendant’s motion for summary judgment dismissing the complaint. Rivera, J.E, Eng, Chambers, Sgroi and Miller, JJ., concur.
CONSENT OF INDEPENDENT ACCOUNTANTS


We consent to the  incorporation by reference in the registration  statements of
Regent Assisted  Living,  Inc. on Form S-8 (File Nos.  333-61239,  333-12159 and
333-12157) and Form S-3 (File No. 333-55769) of our report dated March 28, 2000,
except for the last paragraph of Note 4, as to which the date is April 20, 2000,
on our  audits of the  consolidated  financial  statements  of  Regent  Assisted
Living,  Inc.  as of December  31, 1999 and 1998,  and for the years then ended,
which report is included in this Annual Report on Form 10-K.



PRICEWATERHOUSECOOPERS LLP


Portland, Oregon
March 28, 2000, except for the last paragraph of Note 4, as to which the date is
      April 20, 2000
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AS OF JUNE 30, 1996 AND THE RELATED STATEMENT OF OPERATIONS FOR THE YEAR
THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-1996
<PERIOD-START>                             JUL-01-1995
<PERIOD-END>                               JUN-30-1996
<CASH>                                           1,695
<SECURITIES>                                         0
<RECEIVABLES>                                   33,698
<ALLOWANCES>                                     5,656
<INVENTORY>                                      1,583
<CURRENT-ASSETS>                                33,428
<PP&E>                                          13,903
<DEPRECIATION>                                   4,958
<TOTAL-ASSETS>                                  69,975
<CURRENT-LIABILITIES>                           13,082
<BONDS>                                              0
<PREFERRED-MANDATORY>                              500
<PREFERRED>                                          0
<COMMON>                                        33,725
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    69,975
<SALES>                                         95,878
<TOTAL-REVENUES>                                95,878
<CGS>                                           46,212
<TOTAL-COSTS>                                   87,696
<OTHER-EXPENSES>                                   913<F1>
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,579
<INCOME-PRETAX>                                  5,690
<INCOME-TAX>                                     2,396
<INCOME-CONTINUING>                              3,294
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                (1,161)<F2>
<CHANGES>                                            0
<NET-INCOME>                                     2,133
<EPS-PRIMARY>                                     0.19
<EPS-DILUTED>                                     0.18
<FN>
<F1>OTHER EXPENSES INCLUDES THE WRITE-OFF OF DEFERRED FINANCING FEES, THE
UNAMORTIZED DISCOUNT ON CERTAIN NOTES PAYABLE REDEEMED IN CONNECTION WITH THE
COMPANY'S INITIAL PUBLIC OFFERING AND INTEREST AND OTHER COSTS INCURRED IN
CONNECTION WITH CERTAIN BRIDGE FINANCING.
<F2>EXTRAORDINARY ITEM REPRESENTS LOSS ON EARLY EXTINGUISHMENT OF DEBT.
</FN>
        

</TABLE>